SHARON FLANAGAN has over 15 years of experience representing companies in a broad range of merger and acquisition transactions, and issuers and underwriters in securities offerings. Some notable transactions include:
- Representing eBay Inc. in the sale of Skype Technologies to Silver Lake Partners for $2 billion;
- Representing Genentech in its collaboration and option to acquire Constellation Pharmaceuticals;
- Representing Hoffmann-La Roche in its acquisition of the worldwide development and commercialization rights to danoprevir from InterMune, Inc. for $175 million; and
- Representing interactive whiteboard maker, SMART Technologies in its dual-listed initial public offering raising $660 million.
Consistently recognized for her work on a number of significant transactions, Sharon was recognized in the 2012 and 2013 editions of Chambers USA in Capital Markets and Corporate/M&A. She has also been recognized in the 2011 through 2014 editions of The Best Lawyers in America in the area of Corporate Law and in 2012, she was named the Best Lawyers’ 2013 San Francisco Corporate Law “Lawyer of the Year.” She was also recommended in Healthcare: Life Sciences, Capital Markets, and M&A in the Legal 500 US 2013. In addition, The American Lawyer named her as one of “45 Under 45” – “the best of the best among young women lawyers in the Am Law 200.” Sharon was named to the Daily Journal’s list of the Top 25 Women Corporate and Transactional Lawyers in California. In 2011, she was also named by Law360 as a Rising Star, earning her a spot as one of their 10 corporate finance rising legal stars under 40. In 2013, The Recorder recognized her as one of its Women Leaders in Technology Law.
Sharon has experience handling acquisitions, divestitures and strategic alliances for a broad range of companies, with a particular focus on lifesciences and technology companies. In addition, she regularly represents companies in their cross-border M&A transactions. For example, she represented PayPal in its acquisition of Zong SA, a mobile payments company in Switzerland. She also represented Genentech in its purchase from Lonza of a cell culture biologic manufacturing facility in Singapore.
Sharon has extensive experience representing issuers and underwriters in a variety of securities offerings, including initial public offerings, follow-on offerings, and registered and 144A debt offerings. She represented DaVita Inc., a Fortune 500 healthcare company, in its acquisition financing for HealthCare Partners, including a $1.25 billion high yield notes offering. She recently represented Merrill Lynch, Pierce, Fenner & Smith Incorporated and Goldman, Sachs & Co. in the initial public offering for retailer, Restoration Hardware.
Sharon advises a number of public companies on corporate governance, disclosure and other SEC compliance matters, as well as ISS/proxy advisory firm matters, stockholder proposals and corporate governance best practices.
Sharon serves as the managing partner of the firm’s San Francisco office.